Home Beauty Health BioNTech begins production on omicron-specific vaccine, to publish data: “BioNTech intends to continue to evaluate other follow-on COVID-19 vaccines candidates, including combination and bivalent vaccines,”

on March 31, 2022
BioNTech begins production on omicron-specific vaccine, to publish data: “BioNTech intends to continue to evaluate other follow-on COVID-19 vaccines candidates, including combination and bivalent vaccines,” submitted by /u/shallah
[link] [comments]


from Health https://ift.tt/RmOrpNq
,
Share To:

Unknown

View Profile

Post A Comment:

0 comments so far,add yours

Subscribe to: Post Comments (Atom)